Evidence map›Paper›PMID 27335400›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

Rescue of the Functional Alterations of Motor Cortical Circuits in Arginase Deficiency by Neonatal Gene Therapy.

Gloria Cantero, Xiao-Bo Liu, Ronald F Mervis, Maria T Lazaro, Stephen D Cederbaum, Peyman Golshani, Gerald S Lipshutz

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. The therapeutic landscape of citrin deficiency.Journal of inherited metabolic disease · 2024
    Review
  3. GABAFrontiers in pharmacology · 2023
    Article
  4. The role and control of arginine levels in arginase 1 deficiency.Journal of inherited metabolic disease · 2023
    Review
  5. Article
  6. CPS1: Looking at an ancient enzyme in a modern light.Molecular genetics and metabolism · 2020
    Review
  7. Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  8. Article
  9. Activation of TRPV1 Contributes to Recurrent Febrile SeizuresFrontiers in cellular neuroscience · 2019
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Gloria CanteroDepartments of Surgery.
Xiao-Bo LiuDepartment of Pathology and Laboratory Medicine, University of California Davis, School of Medicine, Sacramento, California 95817.
Ronald F MervisNeurostructural Research Labs, Tampa, Florida 33637.
Maria T LazaroNeurology.
Stephen D CederbaumPediatrics, Human Genetics, Intellectual and Developmental Disabilities Research Center, University of California Los Angeles, Los Angeles, California 90095, Semel Institute for Neuroscience, Los Angeles, California 90095, and.
Peyman GolshaniNeurology, Intellectual and Developmental Disabilities Research Center, University of California Los Angeles, Los Angeles, California 90095, Semel Institute for Neuroscience, Los Angeles, California 90095, and West Los Angeles Veterans Affairs Medical Center, Los Angeles, California 90073.
Gerald S LipshutzDepartments of Surgery, Psychiatry, Medicine, and Molecular and Medical Pharmacology, David Geffen School of Medicine, and Intellectual and Developmental Disabilities Research Center, University of California Los Angeles, Los Angeles, California 90095, Semel Institute for Neuroscience, Los Angeles, California 90095, and glipshutz@mednet.ucla.edu.
Neurology, Inc · USImmunovaccine (Canada) · CAUniversity of California, Davis · USUniversity of California, Los Angeles · US

Funding

Optogenetic treatment of social behavior in autismR01MH101198 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GOLSHANI, PEYMAN · 2013 to 2017
$2.0M
Pathophysiology and Gene Replacement Strategies for Arginase DeficiencyR01NS071076 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LIPSHUTZ, GERALD S · 2010 to 2014
$1.7M
NIMH NIH HHS R01 MH101198NINDS NIH HHS R01 NS071076
6 · The paper itself

Abstract

unlabelledArginase 1 deficiency is a urea cycle disorder associated with hyperargininemia, spastic diplegia, loss of ambulation, intellectual disability, and seizures. To gain insight on how loss of arginase expression affects the excitability and synaptic connectivity of the cortical neurons in the developing brain, we used anatomical, ultrastructural, and electrophysiological techniques to determine how single-copy and double-copy arginase deletion affects cortical circuits in mice. We find that the loss of arginase 1 expression results in decreased dendritic complexity, decreased excitatory and inhibitory synapse numbers, decreased intrinsic excitability, and altered synaptic transmission in layer 5 motor cortical neurons. Hepatic arginase 1 gene therapy using adeno-associated virus rescued nearly all these abnormalities when administered to neonatal homozygous knock-out animals. Therefore, gene therapeutic strategies can reverse physiological and anatomical markers of arginase 1 deficiency and therefore may be of therapeutic benefit for the neurological disabilities in this syndrome. SIGNIFICANCE STATEMENT: These studies are one of the few investigations to try to understand the underlying neurological dysfunction that occurs in urea cycle disorders and the only to examine arginase deficiency. We have demonstrated by multiple modalities that, in murine layer 5 cortical neurons, a gradation of abnormalities exists based on the functional copy number of arginase: intrinsic excitability is altered, there is decreased density in asymmetrical and perisomatic synapses, and analysis of the dendritic complexity is lowest in the homozygous knock-out. With neonatal administration of adeno-associated virus expressing arginase, there is near-total recovery of the abnormalities in neurons and cortical circuits, supporting the concept that neonatal gene therapy may prevent the functional abnormalities that occur in arginase deficiency.

Indexed as

Genetic TherapyAction PotentialsAmmoniaAnimalsAnimals, NewbornArginaseDisease Models, AnimalHyperargininemiaIn Vitro TechniquesMiceMice, TransgenicMotor CortexNerve NetNeuronsPicrotoxinRecovery of FunctionAmmoniaArg1 protein, mouseArginasePicrotoxinSodium Channel BlockersTetrodotoxinadeno-associated virusarginase deficiencyelectrophysiologygene therapymotor cortexsynapses

Identifiers

PMID27335400
PMCPMC4916246
OpenAlexW2467180816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.